Acro Biomedical (ACBM) EBIT Growth (1y) (2017 - 2025)
Acro Biomedical (ACBM) EBIT Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 78.40% |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | -183.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -183.52% |
| Sep 30, 2025 | -1,163.99% |
| Jun 30, 2025 | -49.83% |
| Mar 31, 2025 | 13.25% |
| Dec 31, 2024 | -99.72% |
| Sep 30, 2024 | 99.43% |
| Jun 30, 2024 | 99.72% |
| Mar 31, 2024 | 99.74% |
| Dec 31, 2023 | 276.35% |
| Sep 30, 2023 | 60.39% |
| Jun 30, 2023 | 20.06% |
| Mar 31, 2023 | -1.91% |
| Dec 31, 2022 | -2.11% |
| Sep 30, 2022 | -34.11% |
| Jun 30, 2022 | -403.76% |
| Mar 31, 2022 | -6,793.35% |
| Sep 30, 2021 | -4,080.34% |
| Jun 30, 2021 | -1,163.83% |
| Mar 31, 2021 | -169.88% |
| Sep 30, 2020 | -10.99% |